Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
Trial details
- Registry ID
- NCT04101227
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter PolymorphismsNCT04101227 | Adial Pharmaceuticals | Phase 3 | Completed | 2022-02-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |